St Leger Tina Amber 4

What Happened

• Tina Amber St Leger, Chief HR Officer at Immunocore Holdings plc (IMCR), had 2,119 restricted stock units (RSUs) vest on Feb 17, 2026. Those RSUs converted into 2,119 ordinary shares at no cash cost. She sold 1,000 of those shares in an open-market sell-to-cover transaction on Feb 18, 2026 for a weighted-average price of $32.35, generating $32,350. The filing also shows a derivative-related disposition associated with the vesting (see footnotes).

Key Details

• Transaction dates and prices:
  • 2026-02-17: 2,119 RSUs vested and converted to 2,119 ordinary shares (reported as exercise/conversion at $0.00).
  • 2026-02-18: 1,000 shares sold in the open market at a weighted avg price of $32.35 (prices ranged $32.17–$32.70).
• Purpose: The sale was a sell-to-cover to satisfy income tax withholding on RSU vesting (footnote F2).
• Remaining RSUs: The original grant was 8,476 RSUs (granted 2/17/2025) vesting in four equal annual installments; after this vesting 6,357 RSUs remain unvested (8,476 − 2,119).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Form 4 was filed on Feb 19, 2026 for transactions on Feb 17–18, 2026 (filed within the usual Form 4 reporting window).
• Footnotes of note:
  • F1: Ordinary shares may be represented by ADSs (1 ADS = 1 Ordinary Share).
  • F2: Sell-to-cover arrangement to satisfy taxes.
  • F3: Reported sale price is a weighted average; per-share prices in the range are available on request.
  • F4/F5: Each RSU equals one ordinary share; the grant and vesting schedule are described.

Context

• These transactions are compensation-related: RSUs vested and were converted to shares, and a portion was sold to cover tax obligations. This is a routine, non-speculative insider sale tied to vesting rather than an opportunistic market sale. The M-code/“exercise or conversion” here reflects conversion of vested RSUs into underlying shares.